
Loading, please wait...

Loading, please wait...

Recent advances in biomaterials research have introduced innovative solutions for complex wound management and soft tissue repair. A novel bacterial cellulose composite membrane has emerged as a promising biomaterial that combines exceptional mechanical strength with biological functionalization. Researchers synthesized bacterial cellulose using Acetobacter pasteurianus static fermentation and reinforced it with marine collagen derived from fish scales. Consequently, this sustainable biocomposite dressing offers a bio-interactive environment that supports cellular migration, tissue organization, and accelerated structural recovery. Clinicians in surgery and dermatology increasingly recognize the need for advanced dressings that go beyond passive protection to actively promote physiological healing.
Developing an effective biomedical material requires precise control over fermentation parameters, yield optimization, and structural integration. In this landmark study, scientists utilized Acetobacter pasteurianus PV549389 under static fermentation to produce high-purity bacterial cellulose nanofiber networks. Furthermore, response surface methodology optimized the culture conditions to maximize biomaterial yield effectively. Statistical analysis of variance confirmed the significance of the optimization model, identifying an ideal nutrient environment comprising 21.3 grams per liter glucose, 4.9 grams per liter peptone, and a pH level of 6.7. Under these optimized conditions, the static culture yielded a maximum bacterial cellulose concentration of 3.99 grams per liter. Subsequently, researchers successfully incorporated collagen extracted from the scales of golden grouper (Epinephelus coioides), effectively converting an abundant fishery waste product into a valuable medical resource. Advanced physicochemical characterization demonstrated a uniform membrane morphology, enhanced thermal stability, and distinct functional group interactions between the cellulosic nanofibers and collagen molecules. As a result, the integrated bacterial cellulose composite membrane maintains structural integrity while providing essential extracellular matrix molecular cues required for cellular adhesion and proliferation.
The biological efficacy of any regenerative wound dressing depends heavily on its cellular compatibility and its ability to stimulate key physiological repair mechanisms. In vitro biological evaluation using dermal fibroblasts demonstrated that the composite scaffold possesses an exceptionally safe cytocompatibility profile without inducing cytotoxic responses. Furthermore, in vitro scratch assay models revealed that the biocomposite membrane significantly accelerated cell migration into denuded wound areas. Specifically, fibroblast wound closure rates reached 91% in the presence of the composite biomaterial, vastly outperforming untreated control environments and isolated polymer treatments. In addition, kinetic measurements indicated rapid wound closure velocity, achieving impressive healing rates of 3.03 percent per hour within the first 24 hours and 1.91 percent per hour at 48 hours post-treatment. These dynamic cellular responses confirm that the biocomposite matrix provides a supportive physical architecture alongside an active signaling microenvironment. Therefore, dermal fibroblasts adhere effectively, proliferate efficiently, and migrate rapidly across the scaffold surface, laying down essential provisional extracellular matrix components during the early stages of cutaneous repair.
To validate these promising cellular findings within a living biological system, researchers conducted in vivo excisional wound healing studies in rat models. Cutaneous wounds treated with the composite membrane demonstrated markedly accelerated clinical closure compared to untreated controls and standard collagen-treated groups. Furthermore, the dressing effectively maintained a moist physiological microenvironment, which prevented tissue desiccation and promoted rapid re-epithelialization across the wound bed. Quantitative macroscopic measurements demonstrated consistent wound contraction and rapid epidermal resurfacing throughout the experimental observation period. In contrast, untreated control wounds exhibited delayed re-epithelialization and prolonged inflammatory phases. Additionally, the mechanical robustness of the composite membrane provided adequate physical protection against external stress, moisture loss, and bacterial contamination. Consequently, the treated tissue transitioned smoothly from the acute inflammatory stage into active proliferative repair and extracellular matrix remodeling. These in vivo findings highlight the superior healing kinetics of the composite biomaterial, proving its potential to overcome classic physiological barriers associated with impaired or slow-healing cutaneous wounds.
Microscopic and histomorphometric analyses provided deep insights into the structural quality and architectural organization of the regenerated skin tissue. Histological sectioning showed that wounds treated with the composite scaffold developed a well-organized, mature epidermal layer with significant thickness averaging 97.5 micrometers. In addition, quantitative histomorphometry revealed elevated collagen deposition reaching 59.4%, representing a substantial increase over untreated control groups. Furthermore, the newly deposited collagen fibers displayed superior architectural organization, forming dense, highly aligned structural bundles characteristic of healthy native dermis. The histological evaluation also demonstrated a marked reduction in inflammatory cell infiltration within the underlying wound bed, indicating that the biocomposite actively mitigates prolonged tissue irritation and secondary tissue damage. Consequently, the attenuated inflammatory response allowed fibroblasts and endothelial cells to reconstruct robust microvascular networks and dermal architecture without excessive scar tissue formation. Overall, these detailed histological analyses confirm that the biocomposite promotes true functional tissue regeneration rather than disorganized, non-functional fibrous tissue repair.
The successful development of this sustainable composite membrane offers substantial clinical advantages for dermatologists, general surgeons, plastic surgeons, and wound care specialists. Chronic non-healing wounds, diabetic foot ulcers, severe thermal burns, and surgical wound dehiscence present complex clinical challenges that require advanced regenerative solutions. Traditional wound dressings often lack the necessary combination of mechanical stability, moisture retention, and active biological signaling required for rapid closure. By uniting the high tensile strength and micro-porous structure of bacterial cellulose with the bioactivity of marine-derived collagen, clinicians gain access to a versatile, highly biocompatible dressing. Moreover, utilizing marine waste products such as fish scales aligns with global sustainability initiatives, reducing raw material costs while maintaining superior biological efficacy. Consequently, this composite biomaterial represents a scalable, eco-friendly option for future clinical translation and commercial development. Future clinical trials in human subjects will further clarify its practical utility in managing complex cutaneous defects, minimizing scar formation, and optimizing patient outcomes in modern regenerative medicine.
The bacterial cellulose composite membrane combines high mechanical strength and superior moisture retention with the active biological cues of marine collagen. Unlike basic traditional dressings that merely cover wounds, this composite scaffold actively stimulates dermal fibroblast migration, accelerates re-epithelialization, and promotes organized collagen deposition. Consequently, it creates an ideal microenvironment that significantly speeds up tissue regeneration while reducing localized inflammation and scar formation in complex wounds.
The collagen used in this biocomposite membrane is extracted from the scales of golden grouper fish, converting an abundant aquaculture waste product into a high-value biomedical material. Sourcing marine collagen avoids potential risks associated with mammalian pathogens and religious dietary restrictions. Furthermore, this eco-friendly strategy lowers raw material costs, rendering advanced regenerative wound dressings more accessible for broad clinical applications in general surgery, plastic surgery, and dermatology.
In vitro scratch assays demonstrated that the composite membrane stimulated up to 91% cell migration in dermal fibroblasts. Furthermore, dynamic kinetic measurements revealed accelerated wound closure rates of 3.03% per hour during the first 24 hours and 1.91% per hour at 48 hours post-application. These quantitative healing rates significantly surpassed those observed in untreated control groups and standard collagen-treated models, confirming superior therapeutic efficacy.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Orabi H et al. Development and characterization of a sustainable bacterial cellulose/collagen composite membrane for enhanced wound healing and tissue regeneration applications. Sci Rep. 2026 Aug 06. doi: undefined. PMID: 42562848.
Gorgieva S, Trček J. Bacterial cellulose: functional modification and wound healing applications. Pharmaceutics. 2019;11(12):619.
Fernandes M et al. Bacterial cellulose/collagen hydrogel for wound healing. Int J Morphol. 2015;33(4):1105-1110.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study demonstrates a sustainable bacterial cellulose/collagen composite membrane (BC/COL) using grouper fish scales. The membrane enhanced dermal fibroblast migration (91%), accelerated wound closure (3.03%/h), increased epidermal thickness (97.5 µm), and promoted collagen deposition (59.4%) in vivo.
Today

A multi-state Indian study by KMCRI reveals alarming cardiovascular risk markers among healthy adolescents and young adults, including hyperhomocysteinemia and early blood vessel damage.
Today

A new study reveals that pregnant women with gestational diabetes show altered neural responses to high-fat visual food cues compared to healthy controls. Using visual evoked potentials, researchers found that these early neurophysiological responses correlate with HbA1c levels and metabolic health.
Today

Global private equity firm KKR has agreed to acquire the Indian hospital operations of Swedish healthcare giant Medicover AB for $1.39 billion. The deal encompasses 24 multi-specialty hospitals and 4,800 beds across South and West India, underscoring major institutional consolidation in private healthcare.
Today

A systematic review comparing biportal endoscopic revision discectomy with open microdiscectomy for recurrent lumbar disc herniation found biportal surgery reduced hospital stays and back pain scores, though evidence remains preliminary due to retrospective study design and serious risk of bias.
Today

Per-protocol analysis of the PRAGUE-25 trial demonstrates that catheter ablation significantly reduces atrial fibrillation burden, hospitalizations, and emergency visits compared to lifestyle modification plus antiarrhythmic drugs in obese patients.
Today